Biliary Tract Surgical Procedures—Advances in Research and Application: 2013 Edition is a ScholarlyBrief™ that delivers timely, authoritative, comprehensive, and specialized information about ZZZAdditional Research in a concise format. The editors have built Biliary Tract Surgical Procedures—Advances in Research and Application: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about ZZZAdditional Research in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Biliary Tract Surgical Procedures—Advances in Research and Application: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.

Minimally Invasive Surgical Procedures—Advances in Research and Application: 2013 Edition is a ScholarlyBrief™ that delivers timely, authoritative, comprehensive, and specialized information about ZZZAdditional Research in a concise format. The editors have built Minimally Invasive Surgical Procedures—Advances in Research and Application: 2013 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about ZZZAdditional Research in this book to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Minimally Invasive Surgical Procedures—Advances in Research and Application: 2013 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/.

The basic researches and clinical studies on biliary tree diseases continue to advance at a rapid pace. The articles in this book were written by recognized medical experts and researchers from North America, Europe, Asia, and Africa and aim to provide state-of-the-art reviews on the current knowledge and advances in the surgery of the biliary tree. It includes the most recent advances in that field, particularly cholangiocarcinoma, biliary tree injuries, and biliary cysts.

First multi-year cumulation covers six years: 1965-70.

Vols. for 1963- include as pt. 2 of the Jan. issue: Medical subject headings.

The Bethesda handbook of clinical oncology has been thoroughly reviewed and Ed it Ed by a group of renowned oncologists from reputed government and private cancer institutes of India to make the contents relevant and useful for the students and practitioners of oncology of the Indian subcontinent and South Asia. Salient features: data and evidences from India and South Asia have been added. All the chapters have been edited and updated as per most recent availableevidences and guidelines. More emphasis has been given to the type of cancers more commonly seen in this part of the world such as head and neck cancer, cancer cervix, breast cancer, etc. Chapters of basics of Radiation oncology and medical oncology have been revised. Additional and relevant information on cancer surgery has been added in each br>Chapter a management Flowchart has been added at the end of each br>Chapter for easy understanding and ready reference in the clinic.

Hepatic-biliary-pancreatic cancers, mainly including hepatocellular carcinoma, cholangiocarcinoma, gallbladder cancer, are highly aggressive malignancies with few treatment options and poor prognoses. Effects of the traditional systemic treatments such as chemotherapy and radiotherapy, are quite limited to hepatic-biliary-pancreatic cancers. For the patients who suffer from hepatic-biliary-pancreatic cancer and lose the opportunity of radical surgery, few targeted drugs are available. Even for the drugs in clinical trial, potential drug targets and prognostic biomarkers for hepatic-biliary-pancreatic cancer are less studied compared to other common cancers such as lung cancer. Prognostic biomarker study is the initiation to explore new drug targets and revelation of the underlying mechanisms of tumor progression.

First multi-year cumulation covers six years: 1965-70.